Literature DB >> 24706749

Structural basis of the binding of Merlin FERM domain to the E3 ubiquitin ligase substrate adaptor DCAF1.

Youjun Li1, Zhiyi Wei2, Junyi Zhang1, Zhou Yang1, Mingjie Zhang3.   

Abstract

The tumor suppressor gene Nf2 product, Merlin, plays vital roles in controlling proper development of organ sizes by specifically binding to a large number of target proteins localized both in cytoplasm and nuclei. The FERM domain of Merlin is chiefly responsible for its binding to target proteins, although the molecular basis governing these interactions are poorly understood due to lack of structural information. Here, we report the crystal structure of the Merlin FERM domain in complex with its binding domain derived from the E3 ubiquitin ligase substrate adaptor DCAF1 (also known as VPRBP). Unlike target binding modes found in ERM proteins, the Merlin-FERM binding domain of DCAF1 folds as a β-hairpin and binds to the α1/β5-groove of the F3 lobe of Merlin-FERM via extensive hydrophobic interactions. In addition to providing the first structural glimpse of a Merlin-FERM·target complex, the structure of the Merlin·DCAF1 complex is likely to be valuable for understanding the interactions of Merlin with its binding partners other than DCAF1.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cell Growth; Cell Polarity; Ezrin; Structural Biology; Tumor Suppressor Gene

Mesh:

Substances:

Year:  2014        PMID: 24706749      PMCID: PMC4031523          DOI: 10.1074/jbc.M114.551184

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain.

Authors:  M A Pearson; D Reczek; A Bretscher; P A Karplus
Journal:  Cell       Date:  2000-04-28       Impact factor: 41.582

2.  ESPript: analysis of multiple sequence alignments in PostScript.

Authors:  P Gouet; E Courcelle; D I Stuart; F Métoz
Journal:  Bioinformatics       Date:  1999-04       Impact factor: 6.937

3.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

4.  Structural determinants of integrin recognition by talin.

Authors:  Begoña García-Alvarez; José M de Pereda; David A Calderwood; Tobias S Ulmer; David Critchley; Iain D Campbell; Mark H Ginsberg; Robert C Liddington
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

5.  Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex.

Authors:  Keisuke Hamada; Toshiyuki Shimizu; Shigenobu Yonemura; Shoichiro Tsukita; Sachiko Tsukita; Toshio Hakoshima
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 6.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

7.  Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.

Authors:  Toshiyuki Shimizu; Azusa Seto; Nobuo Maita; Keisuke Hamada; Shoichiro Tsukita; Sachiko Tsukita; Toshio Hakoshima
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

8.  The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Authors:  H Morrison; L S Sherman; J Legg; F Banine; C Isacke; C A Haipek; D H Gutmann; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

9.  Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain.

Authors:  K Hamada; T Shimizu; T Matsui; S Tsukita; T Hakoshima
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

10.  The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product.

Authors:  Beom Sik Kang; David R Cooper; Yancho Devedjiev; Urszula Derewenda; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-02-21
View more
  6 in total

1.  Myosin MyTH4-FERM structures highlight important principles of convergent evolution.

Authors:  Vicente José Planelles-Herrero; Florian Blanc; Serena Sirigu; Helena Sirkia; Jeffrey Clause; Yannick Sourigues; Daniel O Johnsrud; Beatrice Amigues; Marco Cecchini; Susan P Gilbert; Anne Houdusse; Margaret A Titus
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-10       Impact factor: 11.205

2.  Structural basis for the phosphorylation-regulated interaction between the cytoplasmic tail of cell polarity protein crumbs and the actin-binding protein moesin.

Authors:  Zhiyi Wei; Youjun Li; Fei Ye; Mingjie Zhang
Journal:  J Biol Chem       Date:  2015-03-19       Impact factor: 5.157

3.  Structural basis of kindlin-mediated integrin recognition and activation.

Authors:  Huadong Li; Yi Deng; Kang Sun; Haibin Yang; Jie Liu; Meiling Wang; Zhang Zhang; Jirong Lin; Chuanyue Wu; Zhiyi Wei; Cong Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

4.  The Structural Basis for Class II Cytokine Receptor Recognition by JAK1.

Authors:  Ryan Ferrao; Heidi J A Wallweber; Hoangdung Ho; Christine Tam; Yvonne Franke; John Quinn; Patrick J Lupardus
Journal:  Structure       Date:  2016-04-28       Impact factor: 5.006

5.  Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.

Authors:  Jahan Ali Khajeh; Jeong Ho Ju; Moussoubaou Atchiba; Marc Allaire; Christopher Stanley; William T Heller; David J E Callaway; Zimei Bu
Journal:  J Mol Biol       Date:  2014-05-29       Impact factor: 5.469

Review 6.  The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions.

Authors:  Ryan Ferrao; Patrick J Lupardus
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-18       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.